Rapid Micro Biosystems, INC Form 4 insider transactions

NASDAQ
Rapid Micro Biosystems' President and CEO, Robert G. Spignesi, Jr., reported the acquisition of shares from performance-based restricted stock units and subsequent sales to cover tax obligations.
NASDAQ
Rapid Micro Biosystems, Inc. director Dafni Bika was granted 50,000 stock options with an exercise price of $3.15, vesting over 36 months.
NASDAQ
Inese Lowenstein, a Director at Rapid Micro Biosystems, was granted 14,300 Restricted Stock Units and 28,650 stock options, aligning her interests with shareholder value.
NASDAQ
Melinda Litherland Pei, a Director at Rapid Micro Biosystems, was granted 14,300 restricted stock units and 28,650 stock options on May 22, 2025, as part of her compensation.
NASDAQ
Rapid Micro Biosystems, Inc. Director Richard S. Kollender was granted 14,300 restricted stock units and 28,650 stock options as part of his compensation, as reported in a recent SEC Form 4 filing.
NASDAQ
Rapid Micro Biosystems, Inc. Director Kirk Malloy was granted 14,300 restricted stock units and options to purchase 28,650 shares of Class A Common Stock, as detailed in a recent SEC Form 4 filing.
NASDAQ
Natale S. Ricciardi, a Director at Rapid Micro Biosystems, was granted 14,300 Restricted Stock Units and 28,650 stock options, aligning his interests with shareholders.
NASDAQ
Robert G. Spignesi Jr., CEO of Rapid Micro Biosystems, reports the disposal of 10,650 shares to cover tax obligations related to vesting restricted stock units.
NASDAQ
Sean Wirtjes, CFO of Rapid Micro Biosystems, reports disposition of shares to cover tax obligations upon vesting of restricted stock units.
NASDAQ
John J. Addington Wilson, COO of Rapid Micro Biosystems, disposed of shares to cover tax obligations related to vesting restricted stock units.
NASDAQ
John J. Addington Wilson, Chief Operating Officer of Rapid Micro Biosystems, received stock options and restricted stock units on February 18, 2025.
NASDAQ
Sean M. Wirtjes, CFO of Rapid Micro Biosystems, was granted stock options and restricted stock units according to a recent SEC Form 4 filing.
NASDAQ
Robert G. Spignesi Jr., CEO of Rapid Micro Biosystems, was granted stock options and restricted stock units, as well as a correction to previously reported withholding amounts.
NASDAQ
John J. Addington Wilson, COO of Rapid Micro Biosystems, Inc., reports the withholding of shares to cover tax obligations upon vesting of restricted stock units.
NASDAQ
Sean Wirtjes, CFO of Rapid Micro Biosystems, reports withholding shares to cover tax obligations upon vesting of restricted stock units.
NASDAQ
Robert G. Spignesi Jr., CEO of Rapid Micro Biosystems, reports the withholding of shares to cover tax obligations upon the vesting of restricted stock units.
NASDAQ
John J. Addington Wilson, Chief Operating Officer of Rapid Micro Biosystems, sold shares to cover tax obligations arising from vesting restricted stock units.
NASDAQ
Sean Wirtjes, CFO of Rapid Micro Biosystems, disposed of shares to cover tax obligations related to vesting restricted stock units.
NASDAQ
Robert G. Spignesi Jr., CEO of Rapid Micro Biosystems, disposed of shares to cover tax obligations related to vesting restricted stock units.
NASDAQ
Director Melinda Litherland Pei of Rapid Micro Biosystems, Inc. reported purchasing shares of Class A Common Stock in two transactions on December 3rd and 5th, 2024.
NASDAQ
A director at Rapid Micro Biosystems, Melinda Litherland Pei, has increased her holdings of Class A Common Stock through open market purchases.
NASDAQ
Director Kirk Malloy of Rapid Micro Biosystems, Inc. purchased 50,000 shares of Class A Common Stock at an average price of $0.9067 on August 8, 2024.
NASDAQ
Sean Wirtjes, CFO of Rapid Micro Biosystems, recently purchased 10,000 shares of the company's Class A Common Stock at $0.78 per share.
NASDAQ
Director Richard S. Kollender of Rapid Micro Biosystems, Inc. purchased 65,000 shares of Class A Common Stock at a weighted average price of $0.7712 on August 6, 2024.
NASDAQ
Robert G. Spignesi Jr., CEO of Rapid Micro Biosystems, Inc., purchased 50,000 shares of Class A Common Stock at $0.768 per share on August 6, 2024.
NASDAQ
Director Natale S. Ricciardi received stock options and restricted stock units from Rapid Micro Biosystems, Inc. on May 23, 2024.
NASDAQ
Director Inese Lowenstein reports acquisition of stock options and restricted stock units in Rapid Micro Biosystems, Inc.
NASDAQ
Director Melinda Litherland Pei received 14,300 shares of Class A Common Stock and options to purchase 28,650 shares of Class A Common Stock from Rapid Micro Biosystems, Inc. on May 23, 2024.
NASDAQ
Director Richard S. Kollender of Rapid Micro Biosystems received stock options and restricted stock units, as well as shares from a pro rata distribution.
NASDAQ
Director Kirk Malloy of Rapid Micro Biosystems, Inc. received stock options and restricted stock units on May 23, 2024.